Skip to content
2000
Volume 3, Issue 3
  • ISSN: 2665-9786
  • E-ISSN: 2665-9794

Abstract

These days, probiotics are commonly used in functional foods or as dietary supplements. But its positive effect goes far beyond the digestive tract. Local effects of probiotics are currently being studied intensively. The aim of this review paper is to provide an overview of the current state of clinical research of local application of probiotics and to present the benefits and opportunities of probiotic formulation development. This review summarizes the local effect of probiotics in the oral cavity and in the nose, which has already been examined in some clinical studies. A local pulmonary effect is also of particular interest. In this case, however, studies were only carried out on animals but already elucidated its potential. Various solid and liquid dosage forms are suitable as vehicles for local application. An improved formulation of probiotic products based on pharmaceutical formulation development might bring many different advantages for the effectiveness and duration of action, but also the stability of the probiotic products. Possibilities for the development of suitable probiotic formulations using different methods are presented and explained in more detail. Despite a large number of clinical studies on local probiotic application reviewed in this article, no major progress has yet been detected regarding probiotic formulation development. Mostly pure bacterial cultures were administered to the test subjects. Nevertheless, there is large potential at this point to further improve the effect of probiotics by developing actual pharmaceutical formulations.

© 2022 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cnt/10.2174/2665978604666221122112434
2022-08-01
2025-08-18

  • From This Site

    /content/journals/cnt/10.2174/2665978604666221122112434
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Joint FAO/WHO Working GroupGuidelines for the Evaluation of Probiotics in Food: Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food.2002Available from: https://4cau4jsaler1zglkq3wnmje1-wpengine.netdna-ssl.com/wp-content/uploads/2019/04/probiotic_guidelines.pdf
    [Google Scholar]
  2. OzenM. DinleyiciE.C. The history of probiotics: The untold story.Benef. Microbes20156215916510.3920/BM2014.0103 25576593
     [Google Scholar]
  3. KitamotoS. Nagao-KitamotoH. HeinR. SchmidtT.M. KamadaN. The bacterial connection between the oral cavity and the gut diseases.J. Dent. Res.20209991021102910.1177/0022034520924633 32464078
     [Google Scholar]
  4. DicksonR.P. Erb-DownwardJ.R. FreemanC.M. McCloskeyL. FalkowskiN.R. HuffnagleG.B. CurtisJ.L. Bacterial topography of the healthy human lower respiratory tract.MBio201781e02287e1610.1128/mBio.02287‑16 28196961
     [Google Scholar]
  5. Dimitri-PinheiroS. SoaresR. BarataP. The microbiome of the nose-friend or foe?Allergy Rhinol.20201111010.1177/2152656720911605 32206384
     [Google Scholar]
  6. SugiuraY. SogaY. YamabeK. TsutaniS. TanimotoI. MaedaH. KokeguchiS. FujiiN. IshimaruF. TanimotoM. NishimuraF. TakashibaS. Total bacterial counts on oral mucosa after using a commercial saliva substitute in patients undergoing hematopoietic cell transplantation.Support. Care Cancer201018339539810.1007/s00520‑009‑0789‑x 19960207
     [Google Scholar]
  7. MooreW.E.C. MooreL.V.H. The bacteria of periodontal diseases.Periodontol.20001994, 51667710.1111/j.1600‑0757.1994.tb00019.x9673163
     [Google Scholar]
  8. NäseL. HatakkaK. SavilahtiE. SaxelinM. PönkäA. PoussaT. KorpelaR. MeurmanJ.H. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children.Caries Res.200135641242010.1159/000047484 11799281
     [Google Scholar]
  9. PeterssonL.G. MagnussonK. HakestamU. BaigiA. TwetmanS. Reversal of primary root caries lesions after daily intake of milk supplemented with fluoride and probiotic lactobacilli in older adults.Acta Odontol. Scand.201169632132710.3109/00016357.2011.568962 21563871
     [Google Scholar]
  10. Stecksén-BlicksC. SjöströmI. TwetmanS. Effect of long-term consumption of milk supplemented with probiotic lactobacilli and fluoride on dental caries and general health in preschool children: a cluster-randomized study.Caries Res.200943537438110.1159/000235581 19690413
     [Google Scholar]
  11. YadavM. PoornimaP. RoshanN.M. PrachiN. VeenaM. NeenaI.E. Evaluation of probiotic milk on salivary mutans streptococci count: an in vivo microbiological study.J. Clin. Pediatr. Dent.2014391232610.17796/jcpd.39.1.u433n8w245511781 25631721
     [Google Scholar]
  12. WattanaratO. MakeudomA. SastrarujiT. PiwatS. TianviwatS. TeanpaisanR. KrisanaprakornkitS. Enhancement of salivary human neutrophil peptide 1–3 levels by probiotic supplementation.BMC Oral Health20151511910.1186/s12903‑015‑0003‑0 25884192
     [Google Scholar]
  13. MeurmanJ.H. AntilaH. SalminenS. Recovery of lactobacillus strain GG (ATCC 53103) from saliva of healthy volunteers after consumption of yoghurt prepared with the bacterium.Microb. Ecol. Health Dis.19947295298
     [Google Scholar]
  14. NikawaH. MakihiraS. FukushimaH. NishimuraH. OzakiY. IshidaK. DarmawanS. HamadaT. HaraK. MatsumotoA. TakemotoT. AimiR. Lactobacillus reuteri in bovine milk fermented decreases the oral carriage of mutans streptococci.Int. J. Food Microbiol.200495221922310.1016/j.ijfoodmicro.2004.03.006 15282133
     [Google Scholar]
  15. BusscherH.J. MulderA.F.J.M. van der MeiH.C. In vitro adhesion to enamel and in vivo colonization of tooth surfaces by Lactobacilli from a bio-yoghurt.Caries Res.199933540340410.1159/000016541 10460966
     [Google Scholar]
  16. ÇaglarE. SandalliN. TwetmanS. KavalogluS. ErgeneliS. SelviS. Effect of yogurt with Bifidobacterium DN-173 010 on salivary mutans streptococci and lactobacilli in young adults.Acta Odontol. Scand.200563631732010.1080/00016350510020070 16512103
     [Google Scholar]
  17. CildirS.K. GermecD. SandalliN. OzdemirF.I. ArunT. TwetmanS. CaglarE. Reduction of salivary mutans Streptococci in orthodontic patients during daily consumption of yoghurt containing probiotic bacteria.Eur. J. Orthod.200931440741110.1093/ejo/cjn108 19193706
     [Google Scholar]
  18. AshwinD. KeV. TaranathM. RamagoniN.K. NaraA. SarpangalaM. Effect of probiotic containing ice-cream on Salivary Mutans Streptococci (SMS) Levels in Children of 6-12 years of age: a randomized controlled double blind study with six-months follow up.J. Clin. Diagn. Res.201592ZC06ZC0910.7860/JCDR/2015/10942.5532 25859515
     [Google Scholar]
  19. ÇaglarE. Onder KuscuO. Selvi KuvvetliS. Kavaloglu CildirS. SandalliN. TwetmanS. Short-term effect of ice-cream containing Bifidobacterium lactis Bb-12 on the number of salivary mutans Streptococci and Lactobacilli.Acta Odontol. Scand.200866315415810.1080/00016350802089467 18568474
     [Google Scholar]
  20. NagarajappaR. DaryaniH. ShardaA.J. AsawaK. BatraM. SanadhyaS. RameshG. Effect of chocobar ice cream containing Bifidobacterium on salivary Streptococcus mutans and Lactobacilli: A Randomised Controlled Trial.Oral Health Prev. Dent.2015133213218 25197733
     [Google Scholar]
  21. SinghR.P. DamleS.G. ChawlaA. Salivary mutans streptococci and lactobacilli modulations in young children on consumption of probiotic ice-cream containing Bifidobacterium lactis Bb12 and lactobacillus acidophilus La5.Acta Odontol. Scand.201169638939410.3109/00016357.2011.572289 21466258
     [Google Scholar]
  22. AholaA.J. Yli-KnuuttilaH. SuomalainenT. PoussaT. AhlströmA. MeurmanJ.H. KorpelaR. Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors.Arch. Oral Biol.2002471179980410.1016/s0003‑9969(02)00112‑7 12446187
     [Google Scholar]
  23. CildirS.K. SandalliN. NazliS. AlpF. CaglarE. A novel delivery system of probiotic drop and its effect on dental caries risk factors in cleft lip/palate children.Cleft Palate Craniofac. J.201249336937210.1597/10‑035 21309653
     [Google Scholar]
  24. Yli-KnuuttilaH. SnällJ. KariK. MeurmanJ.H. Colonization of Lactobacillus rhamnosus GG in the oral cavity.Oral Microbiol. Immunol.200621212913110.1111/j.1399‑302X.2006.00258.x 16476023
     [Google Scholar]
  25. ÇaglarE. Kavaloglu CildirS. ErgeneliS. SandalliN. TwetmanS. Salivary mutans Streptococci and Lactobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55730 by straws or tablets.Acta Odontol. Scand.200664531431810.1080/00016350600801709 16945898
     [Google Scholar]
  26. MoleyarV. NarasimhamP. Antibacterial activity of essential oil components.Int. J. Food Microbiol.199216433734210.1016/0168‑1605(92)90035‑2 1457292
     [Google Scholar]
  27. DeansS.G. RitchieG. Antibacterial properties of plant essential oils.Int. J. Food Microbiol.19875216518010.1016/0168‑1605(87)90034‑1
     [Google Scholar]
  28. BurtS. Essential oils: Their antibacterial properties and potential applications in foods-a review.Int. J. Food Microbiol.200494322325310.1016/j.ijfoodmicro.2004.03.022 15246235
     [Google Scholar]
  29. MontaltoM. VastolaM. MarigoL. CovinoM. GraziosettoR. CuriglianoV. SantoroL. CuocoL. MannaR. GasbarriniG. Probiotic treatment increases salivary counts of lactobacilli: a double-blind, randomized, controlled study.Digestion2004691535610.1159/000076559 14755153
     [Google Scholar]
  30. JindalG. PandeyR.K. AgarwalJ. SinghM. A comparative evaluation of probiotics on salivary mutans Streptococci counts in Indian children.Eur. Arch. Paediatr. Dent.201112421121510.1007/BF03262809 21806906
     [Google Scholar]
  31. KangM.S. ChungJ. KimS.M. YangK.H. OhJ.S. Effect of Weissella cibaria isolates on the formation of Streptococcus mutans biofilm.Caries Res.200640541842510.1159/000094288 16946611
     [Google Scholar]
  32. ZahradnikR.T. MagnussonI. WalkerC. McDonellE. HillmanC.H. HillmanJ.D. Preliminary assessment of safety and effectiveness in humans of ProBiora3 ™, a probiotic mouthwash.J. Appl. Microbiol.2009107268269010.1111/j.1365‑2672.2009.04243.x 19486429
     [Google Scholar]
  33. JothikaM. VanajassunP.P. SomeshwarB. Effectiveness of probiotic, chlorhexidine and fluoride mouthwash against Streptococcus mutans - Randomized, single-blind, in vivo study.J. Int. Soc. Prev. Community Dent.201557Suppl. 14410.4103/2231‑0762.156153 25984467
     [Google Scholar]
  34. MarttinenA. HaukiojaA. KarjalainenS. NylundL. SatokariR. ÖhmanC. HolgersonP. TwetmanS. SöderlingE. Short-term consumption of probiotic Lactobacilli has no effect on acid production of supragingival plaque.Clin. Oral Investig.201216379780310.1007/s00784‑011‑0584‑1 21732090
     [Google Scholar]
  35. CaglarE. KuscuO.O. CildirS.K. KuvvetliS.S. SandalliN. A probiotic lozenge administered medical device and its effect on salivary mutans Streptococci and Lactobacilli.Int. J. Paediatr. Dent.20081813539 18086024
     [Google Scholar]
  36. ChuangL.C. HuangC.S. Ou-YangL.W. LinS.Y. Probiotic Lactobacillus paracasei effect on cariogenic bacterial flora.Clin. Oral Investig.201115447147610.1007/s00784‑010‑0423‑9 20502929
     [Google Scholar]
  37. ÇaglarE. KavalogluS.C. KuscuO.O. SandalliN. HolgersonP.L. TwetmanS. Effect of chewing gums containing xylitol or probiotic bacteria on salivary mutans Streptococci and Lactobacilli.Clin. Oral Investig.200711442542910.1007/s00784‑007‑0129‑9 17574481
     [Google Scholar]
  38. KellerM.K. HasslöfP. Stecksén-BlicksC. TwetmanS. Co-aggregation and growth inhibition of probiotic Lactobacilli and clinical isolates of mutans Streptococci: An in vitro study.Acta Odontol. Scand.201169526326810.3109/00016357.2011.554863 21306197
     [Google Scholar]
  39. TwetmanL. LarsenU. FiehnN.E. Stecksén-BlicksC. TwetmanS. Coaggregation between probiotic bacteria and caries-associated strains: An in vitro study.Acta Odontol. Scand.200967528428810.1080/00016350902984237 19479452
     [Google Scholar]
  40. Simark-MattssonC. EmilsonC-G. Grahn Ha˚kansson, E.; Jacobsson, C.; Roos, K.; Holm, S. Lactobacillus-mediated interference of mutans streptococci in caries-free vs. caries-active subjects.Eur. J. Oral Sci.2007115430831410.1111/j.1600‑0722.2007.00458.x 17697171
     [Google Scholar]
  41. HaukiojaA. SöderlingE. TenovuoJ. Acid production from sugars and sugar alcohols by probiotic Lactobacilli and Bifidobacteria in vitro.Caries Res.200842644945310.1159/000163020 18931494
     [Google Scholar]
  42. SlawikS. StaufenbielI. SchilkeR. NickschS. WeinspachK. StieschM. EberhardJ. Probiotics affect the clinical inflammatory parameters of experimental gingivitis in humans.Eur. J. Clin. Nutr.201165785786310.1038/ejcn.2011.45 21448219
     [Google Scholar]
  43. StaabB. EickS. KnöflerG. JentschH. The influence of a probiotic milk drink on the development of gingivitis: A pilot study.J. Clin. Periodontol.2009361085085610.1111/j.1600‑051X.2009.01459.x 19682173
     [Google Scholar]
  44. KuruB.E. LalemanI. Yalnızoğlu, T.; Kuru, L.; Teughels, W. The Influence of a Bifidobacterium animalis probiotic on gingival health: a randomized controlled clinical Trial.J. Periodontol.201788111115112310.1902/jop.2017.170213 28753102
     [Google Scholar]
  45. SabatiniS. LauritanoD. CandottoV. SilvestreF.J. NardiG.M. Oral probiotics in the management of gingivitis in diabetic patients: A double blinded randomized controlled study.J. Biol. Regul. Homeost. Agents2017312Suppl. 1197202 28691473
     [Google Scholar]
  46. IniestaM. HerreraD. MonteroE. ZurbriggenM. MatosA.R. MarínM.J. Sánchez-BeltránM.C. Llama-PalacioA. SanzM. Probiotic effects of orally administered Lactobacillus reuteri -containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial.J. Clin. Periodontol.201239873674410.1111/j.1600‑051X.2012.01914.x 22694350
     [Google Scholar]
  47. MonteroE. IniestaM. RodrigoM. MarínM.J. FigueroE. HerreraD. SanzM. Clinical and microbiological effects of the adjunctive use of probiotics in the treatment of gingivitis: A randomized controlled clinical trial.J. Clin. Periodontol.201744770871610.1111/jcpe.12752 28556062
     [Google Scholar]
  48. HallströmH. LindgrenS. Yucel-LindbergT. DahlénG. RenvertS. TwetmanS. Effect of probiotic lozenges on inflammatory reactions and oral biofilm during experimental gingivitis.Acta Odontol. Scand.2013713-482883310.3109/00016357.2012.734406 23294143
     [Google Scholar]
  49. LeeJ.K. KimS.J. KoS.H. OuwehandA.C. MaD.S. Modulation of the host response by probiotic Lactobacillus brevis CD2 in experimental gingivitis.Oral Dis.201521670571210.1111/odi.12332 25720615
     [Google Scholar]
  50. TwetmanS. DerawiB. KellerM. EkstrandK. Yucel-LindbergT. Stecksén-BlicksC. Short-term effect of chewing gums containing probiotic Lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid.Acta Odontol. Scand.2009671192410.1080/00016350802516170 18985460
     [Google Scholar]
  51. AlkayaB. LalemanI. KeceliS. OzcelikO. Cenk HaytacM. TeughelsW. Clinical effects of probiotics containing Bacillus species on gingivitis: A pilot randomized controlled trial.J. Periodontal Res.201752349750410.1111/jre.12415 27859252
     [Google Scholar]
  52. NoordinK. KaminS. The effect of Probiotic mouthrinse on plaque and gingival inflammation.Ann. Dent.2007141192510.22452/adum.vol14no1.4
     [Google Scholar]
  53. İnceG GürsoyH İpçiŞ.D. CakarG Emekli-AlturfanE YılmazS Clinical and Biochemical Evaluation of Lozenges Containing Lactobacillus reuteri as an adjunct to non-surgical periodontal therapy in chronic periodontitis.J. Periodontol.201586674675410.1902/jop.2015.14061225741580
     [Google Scholar]
  54. TeughelsW. DurukanA. OzcelikO. PauwelsM. QuirynenM. HaytacM.C. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: A randomized placebo‐controlled study.J. Clin. Periodontol.201340111025103510.1111/jcpe.12155 24164569
     [Google Scholar]
  55. TekceM. InceG. GursoyH. Dirikan IpciS. CakarG. KadirT. Yılmaz, S. Clinical and microbiological effects of probiotic lozenges in the treatment of chronic periodontitis: a 1-year follow-up study.J. Clin. Periodontol.201542436337210.1111/jcpe.12387 25728888
     [Google Scholar]
  56. VicarioM. SantosA. ViolantD. NartJ. GinerL. Clinical changes in periodontal subjects with the probiotic Lactobacillus reuteri Prodentis: A preliminary randomized clinical trial.Acta Odontol. Scand.2013713-481381910.3109/00016357.2012.734404 23176716
     [Google Scholar]
  57. VivekanandaM.R. VandanaK.L. BhatK.G. Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial.J. Oral Microbiol.201021534410.3402/jom.v2i0.5344 21523225
     [Google Scholar]
  58. ShimauchiH. MayanagiG. NakayaS. MinamibuchiM. ItoY. YamakiK. HirataH. Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: A randomized, double-blind, placebo-controlled study.J. Clin. Periodontol.2008351089790510.1111/j.1600‑051X.2008.01306.x 18727656
     [Google Scholar]
  59. MayanagiG. KimuraM. NakayaS. HirataH. SakamotoM. BennoY. ShimauchiH. Probiotic effects of orally administered Lactobacillus salivarius WB21-containing tablets on periodontopathic bacteria: a double-blinded, placebo-controlled, randomized clinical trial.J. Clin. Periodontol.200936650651310.1111/j.1600‑051X.2009.01392.x 19453574
     [Google Scholar]
  60. IshikawaH. AibaY. NakanishiM. Oh-hashiY. KogaY. Suppression of Periodontal Pathogenic Bacteria in the Saliva of Humans by the Administration of Lactobacillus salivarius TI2711.Nippon Shishubyo Gakkai Kaishi200345110511210.2329/perio.45.105
     [Google Scholar]
  61. RicciaD.N.D. BizziniF. PerilliM.G. PolimeniA. TrinchieriV. AmicosanteG. CifoneM.G. Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease.Oral Dis.200713437638510.1111/j.1601‑0825.2006.01291.x 17577323
     [Google Scholar]
  62. MoralesA. CarvajalP. SilvaN. HernandezM. GodoyC. RodriguezG. CabelloR. Garcia-SesnichJ. HoareA. DiazP.I. GamonalJ. Clinical Effects of Lactobacillus rhamnosus in non-surgical treatment of chronic periodontitis: a randomized placebo-controlled trial with 1-year follow-up.J. Periodontol.201687894495210.1902/jop.2016.150665 26944407
     [Google Scholar]
  63. MaekawaT. HajishengallisG. Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss.J. Periodontal Res.201449678579110.1111/jre.12164 24483135
     [Google Scholar]
  64. SutulaJ. CoulthwaiteL. ThomasL. VerranJ. The effect of a commercial probiotic drink on oral microbiota in healthy complete denture wearers.Microb. Ecol. Health Dis.20122323 23990840
     [Google Scholar]
  65. SutulaJ. CoulthwaiteL.A. ThomasL.V. VerranJ. The effect of a commercial probiotic drink containing Lactobacillus casei strain Shirota on oral health in healthy dentate people.Microb. Ecol. Health Dis.20132424 24179468
     [Google Scholar]
  66. HatakkaK. AholaA.J. Yli-KnuuttilaH. RichardsonM. PoussaT. MeurmanJ.H. KorpelaR. Probiotics reduce the prevalence of oral candida in the elderly--a randomized controlled trial.J. Dent. Res.200786212513010.1177/154405910708600204 17251510
     [Google Scholar]
  67. IshikawaK.H. MayerM.P.A. MiyazimaT.Y. MatsubaraV.H. SilvaE.G. PaulaC.R. CamposT.T. NakamaeA.E.M. A multispecies probiotic reduces oral Candida colonization in denture wearers.J. Prosthodont.201524319419910.1111/jopr.12198 25143068
     [Google Scholar]
  68. SantosA.L. JorgeA.O.C. SantosS.S.F. SilvaC.R.G. LeãoM.V.P. Influence of probiotics on Candida presence and IgA anti-Candida in the oral cavity.Braz. J. Microbiol.200940496096410.1590/S1517‑83822009000400030 24031447
     [Google Scholar]
  69. MendonçaF.H.B.P. SantosS.S.F. FariaI.S. Gonçalves e SilvaC.R. JorgeA.O.C. LeãoM.V.P. Effects of probiotic bacteria on Candida presence and IgA anti-Candida in the oral cavity of elderly.Braz. Dent. J.201223553453810.1590/S0103‑64402012000500011 23306230
     [Google Scholar]
  70. Kraft-BodiE. JørgensenM.R. KellerM.K. KragelundC. TwetmanS. Effect of probiotic bacteria on oral Candida in frail elderly.J. Dent. Res.2015949Suppl.181S186S10.1177/0022034515595950 26202995
     [Google Scholar]
  71. LiD. LiQ. LiuC. LinM. LiX. XiaoX. ZhuZ. GongQ. ZhouH. Efficacy and safety of probiotics in the treatment of Candida -associated stomatitis.Mycoses201457314114610.1111/myc.12116 23952962
     [Google Scholar]
  72. BollenC.M.L. BeiklerT. Halitosis: The multidisciplinary approach.Int. J. Oral Sci.201242556310.1038/ijos.2012.39 22722640
     [Google Scholar]
  73. KangM.S. KimB.G. ChungJ. LeeH.C. OhJ.S. Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds.J. Clin. Periodontol.200633322623210.1111/j.1600‑051X.2006.00893.x 16489950
     [Google Scholar]
  74. PenalaS. KalakondaB. PathakotaK. JayakumarA. KoppoluP. LakshmiB. PandeyR. MishraA. Efficacy of local use of probiotics as an adjunct to scaling and root planing in chronic periodontitis and halitosis: A randomized controlled trial.J. Res. Pharm. Pract.201652869310.4103/2279‑042X.179568 27162801
     [Google Scholar]
  75. IwamotoT. SuzukiN. TanabeK. TakeshitaT. HirofujiT. Effects of probiotic Lactobacillus salivarius WB21 on halitosis and oral health: An open-label pilot trial.Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.2010110220120810.1016/j.tripleo.2010.03.032 20659698
     [Google Scholar]
  76. BurtonJ.P. ChilcottC.N. MooreC.J. SpeiserG. TaggJ.R. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters.J. Appl. Microbiol.2006100475476410.1111/j.1365‑2672.2006.02837.x 16553730
     [Google Scholar]
  77. BurtonJ.P. WescombeP.A. MooreC.J. ChilcottC.N. TaggJ.R. Safety assessment of the oral cavity probiotic Streptococcus salivarius K12.Appl. Environ. Microbiol.20067243050305310.1128/AEM.72.4.3050‑3053.2006 16598017
     [Google Scholar]
  78. JamaliZ. AminabadiN.A. SamieiM. Sighari DeljavanA. ShokraviM. ShiraziS. Impact of chlorhexidine pretreatment followed by probiotic Streptococcus salivarius strain k12 on halitosis in children: a randomised controlled clinical trial.Oral Health Prev. Dent.2016144305313 27508274
     [Google Scholar]
  79. KellerM.K. BardowA. JensdottirT. LykkeaaJ. TwetmanS. Effect of chewing gums containing the probiotic bacterium Lactobacillus reuteri on oral malodour.Acta Odontol. Scand.201270324625010.3109/00016357.2011.640281 22182258
     [Google Scholar]
  80. ChenC.H. LiouM.L. LeeC.Y. ChangM.C. KuoH.Y. ChangT.H. Diversity of nasal microbiota and its interaction with surface microbiota among residents in healthcare institutes.Sci. Rep.201991617510.1038/s41598‑019‑42548‑5 30992494
     [Google Scholar]
  81. KumpitschC. KoskinenK. SchöpfV. Moissl-EichingerC. The microbiome of the upper respiratory tract in health and disease.BMC Biol.20191718710.1186/s12915‑019‑0703‑z 31699101
     [Google Scholar]
  82. CharlsonE.S. ChenJ. Custers-AllenR. BittingerK. LiH. SinhaR. HwangJ. BushmanF.D. CollmanR.G. Disordered microbial communities in the upper respiratory tract of cigarette smokers.PLoS One2010512e1521610.1371/journal.pone.0015216 21188149
     [Google Scholar]
  83. De BoeckI. van den BroekM.F.L. AllonsiusC.N. SpacovaI. WittouckS. MartensK. WuytsS. CauwenberghsE. JokicevicK. VandenheuvelD. EilersT. LemarcqM. De RudderC. ThysS. TimmermansJ.P. VroegopA.V. VerplaetseA. Van de WieleT. KiekensF. HellingsP.W. VandervekenO.M. LebeerS. Lactobacilli have a niche in the human nose.Cell Rep.202031810767410.1016/j.celrep.2020.107674 32460009
     [Google Scholar]
  84. GreenbergD. Givon-LaviN. BroidesA. BlancovichI. PeledN. DaganR. The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers.Clin. Infect. Dis.200642789790310.1086/500935 16511750
     [Google Scholar]
  85. FeazelL.M. RobertsonC.E. RamakrishnanV.R. FrankD.N. Microbiome complexity and Staphylococcus aureus in chronic rhinosinusitis.Laryngoscope2012122246747210.1002/lary.22398 22253013
     [Google Scholar]
  86. ChoiE.B. HongS.W. KimD.K. JeonS.G. KimK.R. ChoS.H. GhoY.S. JeeY.K. KimY.K. Decreased diversity of nasal microbiota and their secreted extracellular vesicles in patients with chronic rhinosinusitis based on a metagenomic analysis.Allergy201469451752610.1111/all.12374 24611950
     [Google Scholar]
  87. LalD. KeimP. DelisleJ. BarkerB. RankM.A. ChiaN. SchuppJ.M. GilleceJ.D. CopeE.K. Mapping and comparing bacterial microbiota in the sinonasal cavity of healthy, allergic rhinitis, and chronic rhinosinusitis subjects.Int. Forum Allergy Rhinol.20177656156910.1002/alr.21934 28481057
     [Google Scholar]
  88. LappanR. ImbrognoK. SikazweC. AndersonD. MokD. CoatesH. VijayasekaranS. BumbakP. BlythC.C. JamiesonS.E. PeacockC.S. A microbiome case-control study of recurrent acute otitis media identified potentially protective bacterial genera.BMC Microbiol.20181811310.1186/s12866‑018‑1154‑3 29458340
     [Google Scholar]
  89. CostaD.J. MarteauP. AmouyalM. PoulsenL.K. HamelmannE. CazaubielM. HousezB. LeuilletS. StavnsbjergM. MolimardP. CourauS. BousquetJ. Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: A double-blind, randomized, placebo-controlled trial (GA2LEN Study).Eur. J. Clin. Nutr.201468560260710.1038/ejcn.2014.13 24569538
     [Google Scholar]
  90. IvoryK. ChambersS.J. PinC. PrietoE. ArquésJ.L. NicolettiC. Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis.Clin. Exp. Allergy20083881282128910.1111/j.1365‑2222.2008.03025.x 18510694
     [Google Scholar]
  91. IvoryK. WilsonA.M. SankaranP. WestwoodM. McCarvilleJ. BrockwellC. ClarkA. DaintyJ.R. Zuidmeer-JongejanL. NicolettiC. Oral delivery of a probiotic induced changes at the nasal mucosa of seasonal allergic rhinitis subjects after local allergen challenge: a randomised clinical trial.PLoS One2013811e7865010.1371/journal.pone.0078650 24260122
     [Google Scholar]
  92. KawaseM. HeF. KubotaA. HiramatsuM. SaitoH. IshiiT. YasuedaH. AkiyamaK. Effect of fermented milk prepared with two probiotic strains on Japanese cedar pollinosis in a double-blind placebo-controlled clinical study.Int. J. Food Microbiol.2009128342943410.1016/j.ijfoodmicro.2008.09.017 18977549
     [Google Scholar]
  93. LiuJ. ChenF.H. QiuS.Q. YangL.T. ZhangH.P. LiuJ.Q. GengX-R. YangG. LiuZ.Q. LiJ. LiuZ.G. LiH.B. YangP-C. Probiotics enhance the effect of allergy immunotherapy on regulating antigen specific B cell activity in asthma patients.Am. J. Transl. Res.201681252565270 28078000
     [Google Scholar]
  94. PengG-C. HsuC-H. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite.Pediatr. Allergy Immunol.200516543343810.1111/j.1399‑3038.2005.00284.x 16101937
     [Google Scholar]
  95. PerrinY. NuttenS. AudranR. BergerB. BibiloniR. WassenbergJ. BarbierN. AubertV. MoulinJ. SinghA. MagliolaC. MercenierA. SpertiniF. Comparison of two oral probiotic preparations in a randomized crossover trial highlights a potentially beneficial effect of Lactobacillus paracasei NCC2461 in patients with allergic rhinitis.Clin. Transl. Allergy201441110.1186/2045‑7022‑4‑1 24393277
     [Google Scholar]
  96. SinghA. Hacini-RachinelF. GosoniuM.L. BourdeauT. HolvoetS. Doucet-LadevezeR. BeaumontM. MercenierA. NuttenS. Immune-modulatory effect of probiotic Bifidobacterium lactis NCC2818 in individuals suffering from seasonal allergic rhinitis to grass pollen: an exploratory, randomized, placebo-controlled clinical trial.Eur. J. Clin. Nutr.201367216116710.1038/ejcn.2012.197 23299716
     [Google Scholar]
  97. TamuraM. ShikinaT. MorihanaT. HayamaM. KajimotoO. SakamotoA. KajimotoY. WatanabeO. NonakaC. ShidaK. NannoM. Effects of probiotics on allergic rhinitis induced by Japanese cedar pollen: randomized double-blind, placebo-controlled clinical trial.Int. Arch. Allergy Immunol.20071431758210.1159/000098318 17199093
     [Google Scholar]
  98. WangM.F. LinH.C. WangY.Y. HsuC.H. Treatment of perennial allergic rhinitis with lactic acid bacteria.Pediatr. Allergy Immunol.200415215215810.1111/j.1399‑3038.2004.00156.x 15059192
     [Google Scholar]
  99. WassenbergJ. NuttenS. AudranR. BarbierN. AubertV. MoulinJ. MercenierA. SpertiniF. Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis.Clin. Exp. Allergy201141456557310.1111/j.1365‑2222.2011.03695.x 21395878
     [Google Scholar]
  100. XiaoJ.Z. KondoS. YanagisawaN. TakahashiN. OdamakiT. IwabuchiN. MiyajiK. IwatsukiK. TogashiH. EnomotoK. EnomotoT. Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial.Clin. Exp. Allergy200636111425143510.1111/j.1365‑2222.2006.02575.x 17083353
     [Google Scholar]
  101. HelinT. HaahtelaS. HaahtelaT. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: A placebo-controlled double-blind study.Allergy200257324324610.1034/j.1398‑9995.2002.1s3299.x 11906339
     [Google Scholar]
  102. RoseM.A. StieglitzF. KöksalA. SchubertR. SchulzeJ. ZielenS. Efficacy of probiotic Lactobacillus GG on allergic sensitization and asthma in infants at risk.Clin. Exp. Allergy20104091398140510.1111/j.1365‑2222.2010.03560.x 20604800
     [Google Scholar]
  103. WestC.E. HammarströmM.L. HernellO. Probiotics in primary prevention of allergic disease - follow-up at 8-9 years of age.Allergy20136881015102010.1111/all.12191 23895631
     [Google Scholar]
  104. HarsonoA. SubrataL.A. EndaryantoA. Immuno- Modulatory Effect of Probiotic and Sublingual Immunotherapy in Asthmatic Children.Folia Medica Indonesiana2009
     [Google Scholar]
  105. OuwehandA.C. NermesM. ColladoM.C. RautonenN. SalminenS. IsolauriE. Specific probiotics alleviate allergic rhinitis during the birch pollen season.World J. Gastroenterol.200915263261326810.3748/wjg.15.3261 19598302
     [Google Scholar]
  106. CiprandiG. ToscaM.A. MilaneseM. CaligoG. RiccaV. Cytokines evaluation in nasal lavage of allergic children after Bacillus clausii administration: A pilot study.Pediatr. Allergy Immunol.200415214815110.1046/j.1399‑3038.2003.00102.x 15059191
     [Google Scholar]
  107. LeeS.C. YangY.H. ChuangS.Y. HuangS.Y. PanW.H. Reduced medication use and improved pulmonary function with supplements containing vegetable and fruit concentrate, fish oil and probiotics in asthmatic school children: A randomised controlled trial.Br. J. Nutr.2013110114515510.1017/S0007114512004692 23211647
     [Google Scholar]
  108. KalliomäkiM. SalminenS. ArvilommiH. KeroP. KoskinenP. IsolauriE. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial.Lancet200135792621076107910.1016/S0140‑6736(00)04259‑8 11297958
     [Google Scholar]
  109. KalliomäkiM. SalminenS. PoussaT. ArvilommiH. IsolauriE. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial.Lancet200336193721869187110.1016/S0140‑6736(03)13490‑3 12788576
     [Google Scholar]
  110. KoppM.V. HennemuthI. HeinzmannA. UrbanekR. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: No clinical effects of Lactobacillus GG supplementation.Pediatrics20081214e850e85610.1542/peds.2007‑1492 18332075
     [Google Scholar]
  111. KukkonenA.K. KuitunenM. SavilahtiE. PelkonenA. MalmbergP. MäkeläM. Airway inflammation in probiotic-treated children at 5 years.Pediatr. Allergy Immunol.201122224925110.1111/j.1399‑3038.2010.01079.x 21332798
     [Google Scholar]
  112. HøstA. Cow’s milk protein allergy and intolerance in infancy. Some clinical, epidemiological and immunological aspects.Pediatr. Allergy Immunol.199455Suppl.136 7704117
     [Google Scholar]
  113. Cortes-PerezN.G. Ah-LeungS. Bermúdez-HumaránL.G. CorthierG. LangellaP. WalJ.M. Adel-PatientK. Allergy therapy by intranasal administration with recombinant Lactococcus lactis Producing bovine beta-lactoglobulin.Int. Arch. Allergy Immunol.20091501253110.1159/000210377 19339799
     [Google Scholar]
  114. Cortes-PerezN.G. Ah-LeungS. Bermúdez-HumaránL.G. CorthierG. WalJ.M. LangellaP. Adel-PatientK. Intranasal coadministration of live lactococci producing interleukin-12 and a major cow’s milk allergen inhibits allergic reaction in mice.Clin. Vaccine Immunol.200714322623310.1128/CVI.00299‑06 17202306
     [Google Scholar]
  115. SchabussovaI. HufnaglK. WildC. NuttenS. ZuercherA.W. MercenierA. WiedermannU. Distinctive anti-allergy properties of two probiotic bacterial strains in a mouse model of allergic poly-sensitization.Vaccine201129101981199010.1016/j.vaccine.2010.12.101 21216308
     [Google Scholar]
  116. MastrangeliG. CorintiS. ButteroniC. AfferniC. BonuraA. BoirivantM. ColomboP. Di FeliceG. Effects of live and inactivated VSL#3 probiotic preparations in the modulation of in vitro and in vivo allergen-induced Th2 responses.Int. Arch. Allergy Immunol.2009150213314310.1159/000218116 19439979
     [Google Scholar]
  117. NembriniC. SichelstielA. KisielowJ. KurrerM. KopfM. MarslandB.J. Bacterial-induced protection against allergic inflammation through a multicomponent immunoregulatory mechanism.Thorax201166975576310.1136/thx.2010.152512 21422039
     [Google Scholar]
  118. SantagatiM. ScillatoM. MuscaridolaN. MetoldoV. La MantiaI. StefaniS. Colonization, safety, and tolerability study of the Streptococcus salivarius 24SMBc nasal spray for its application in upper respiratory tract infections.Eur. J. Clin. Microbiol. Infect. Dis.201534102075208010.1007/s10096‑015‑2454‑2 26205666
     [Google Scholar]
  119. SydorchukA. MoskaliukV. RandiukY. SydorchukL. Influence of bacteriotherapy on nasal and tonsillar microbiota in influenza patients.Adv. Sci. J.201620161868910.15550/ASJ.2016.01.086
     [Google Scholar]
  120. UeharaY. NakamaH. AgematsuK. UchidaM. KawakamiY. Abdul FattahA.S.M. MaruchiN. Bacterial interference among nasal inhabitants: Eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp.J. Hosp. Infect.200044212713310.1053/jhin.1999.0680 10662563
     [Google Scholar]
  121. RoosK. Simark-MattssonC. Grahn HåkanssonE. LarssonL. SandbergT. ÅhrénC. Can probiotic Lactobacilli eradicate persistent carriage of meticillin-resistant Staphylococcus aureus?J. Hosp. Infect.2011781777810.1016/j.jhin.2011.01.010 21371778
     [Google Scholar]
  122. RautavaS. SalminenS. IsolauriE. Specific probiotics in reducing the risk of acute infections in infancy – a randomised, double-blind, placebo-controlled study.Br. J. Nutr.2009101111722172610.1017/S0007114508116282 18986600
     [Google Scholar]
  123. RerksuppapholS. RerksuppapholL. Randomized controlled trial of probiotics to reduce common cold in schoolchildren.Pediatr. Int.201254568268710.1111/j.1442‑200X.2012.03647.x 22507276
     [Google Scholar]
  124. de VreseM. WinklerP. RautenbergP. HarderT. NoahC. LaueC. OttS. HampeJ. SchreiberS. HellerK. SchrezenmeirJ. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: A double blind, randomized, controlled trial.Clin. Nutr.200524448149110.1016/j.clnu.2005.02.006 16054520
     [Google Scholar]
  125. BerggrenA. Lazou AhrénI. LarssonN. ÖnningG. Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections.Eur. J. Nutr.201150320321010.1007/s00394‑010‑0127‑6 20803023
     [Google Scholar]
  126. LuotoR. RuuskanenO. WarisM. KalliomäkiM. SalminenS. IsolauriE. Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: A randomized, placebo-controlled trial.J. Allergy Clin. Immunol.2014133240541310.1016/j.jaci.2013.08.020 24131826
     [Google Scholar]
  127. WeizmanZ. AsliG. AlsheikhA. Effect of a probiotic infant formula on infections in child care centers: Comparison of two probiotic agents.Pediatrics200511515910.1542/peds.2004‑1815 15629974
     [Google Scholar]
  128. SmithT.J. Rigassio-RadlerD. DenmarkR. HaleyT. Touger-DeckerR. Effect of Lactobacillus rhamnosus LGG® and Bifidobacterium animalis ssp. lactis BB-12® on health-related quality of life in college students affected by upper respiratory infections.Br. J. Nutr.2013109111999200710.1017/S0007114512004138 23020819
     [Google Scholar]
  129. TurnerR.B. WoodfolkJ.A. BorishL. SteinkeJ.W. PatrieJ.T. MuehlingL.M. LahtinenS. LehtinenM.J. Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection - a randomised controlled trial.Benef. Microbes20178220721510.3920/BM2016.0160 28343401
     [Google Scholar]
  130. KekkonenR.A. VasankariT.J. VuorimaaT. HaahtelaT. JulkunenI. KorpelaR. The effect of probiotics on respiratory infections and gastrointestinal symptoms during training in marathon runners.Int. J. Sport Nutr. Exerc. Metab.200717435236310.1123/ijsnem.17.4.352 17962710
     [Google Scholar]
  131. Cobo SanzJ.M. MateosJ.A. Muñoz ConejoA. Efecto de Lactobacillus casei sobre la incidencia de procesos infeeciosos en niñios/as.Nutr. Hosp.2006214547551 16913215
     [Google Scholar]
  132. FujitaR. IimuroS. ShinozakiT. SakamakiK. UemuraY. TakeuchiA. MatsuyamaY. OhashiY. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: A multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population.Am. J. Infect. Control201341121231123510.1016/j.ajic.2013.04.005 23890374
     [Google Scholar]
  133. GlückU. GebbersJ.O. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and β-hemolytic Streptococci).Am. J. Clin. Nutr.200377251752010.1093/ajcn/77.2.517 12540416
     [Google Scholar]
  134. HatakkaK. SavilahtiE. PönkäA. MeurmanJ.H. PoussaT. NäseL. SaxelinM. KorpelaR. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised.BMJ20013227298132710.1136/bmj.322.7298.1327 11387176
     [Google Scholar]
  135. HojsakI. Abdović S.; Szajewska, H.; Milošević M.; Krznarić Ž.; Kolaček, S. Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections.Pediatrics20101255e1171e117710.1542/peds.2009‑2568 20403940
     [Google Scholar]
  136. HojsakI. SnovakN. Abdović S.; Szajewska, H.; Mišak, Z.; Kolaček, S. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: A randomized, double-blind, placebo-controlled trial.Clin. Nutr.201029331231610.1016/j.clnu.2009.09.008 19896252
     [Google Scholar]
  137. MakinoS. IkegamiS. KumeA. HoriuchiH. SasakiH. OriiN. Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1.Br. J. Nutr.20101047998100610.1017/S000711451000173X 20487575
     [Google Scholar]
  138. LeandraM. Self-administered topical probiotic is beneficial for refractory CRS.Coc. Cent. Reg. Control. Trials2016155P154P15510.1177/0194599816655336i
     [Google Scholar]
  139. EndamL.M. AlromaihS. GonzalezE. MadrenasJ. CousineauB. RenteriaA.E. DesrosiersM. Intranasal application of Lactococcus lactis W136 is safe in chronic rhinosinusitis patients with previous sinus surgery.Front. Cell. Infect. Microbiol.20201044010.3389/fcimb.2020.00440 33154953
     [Google Scholar]
  140. MårtenssonA. GreiffL. LameiS.S. LindstedtM. OlofssonT.C. VasquezA. CervinA. Effects of a honeybee lactic acid bacterial microbiome on human nasal symptoms, commensals, and biomarkers.Int. Forum Allergy Rhinol.20166995696310.1002/alr.21762 27080343
     [Google Scholar]
  141. MårtenssonA. AbolhalajM. LindstedtM. MårtenssonA. OlofssonT.C. VásquezA. GreiffL. CervinA. Clinical efficacy of a topical lactic acid bacterial microbiome in chronic rhinosinusitis: A randomized controlled trial.Laryngoscope Investig. Otolaryngol.20172641041610.1002/lio2.93 29299516
     [Google Scholar]
  142. MukerjiS.S. PynnonenM.A. KimH.M. SingerA. TaborM. TerrellJ.E. Probiotics as adjunctive treatment for chronic rhinosinusitis: A randomized controlled trial.Otolaryngol. Head Neck Surg.2009140220220810.1016/j.otohns.2008.11.020 19201289
     [Google Scholar]
  143. KitzR. MartensU. ZiesenißE. EnckP. RoseM. Probiotic E.faecalis — adjuvant therapy in children with recurrent rhinosinusitis.Open Med.20127336236510.2478/s11536‑011‑0160‑8
     [Google Scholar]
  144. ClelandE.J. DrillingA. BassiouniA. JamesC. VreugdeS. WormaldP.J. Probiotic manipulation of the chronic rhinosinusitis microbiome.Int. Forum Allergy Rhinol.20144430931410.1002/alr.21279 24415658
     [Google Scholar]
  145. GrahnE. HolmS.E. EkedahlC. RoosK. Interference of α-hemolytic streptococci isolated from tonsillar surface on β-hemolytic streptococci (Streptococcus pyogenes) — A methodological study. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale. A, Medizinische Mikrobiologie.Infektionskrankheiten und Parasitologie1983254459468
     [Google Scholar]
  146. RoosK. HåkanssonE.G. HolmS. Effect of recolonisation with “interfering” alpha streptococci on recurrences of acute and secretory otitis media in children: Randomised placebo controlled trial.BMJ2001322728021021210.1136/bmj.322.7280.210 11159619
     [Google Scholar]
  147. TanoK. Grahn HåkanssonE. HolmS.E. HellströmS. A nasal spray with alpha-haemolytic Streptococci as long term prophylaxis against recurrent otitis media.Int. J. Pediatr. Otorhinolaryngol.2002621172310.1016/S0165‑5876(01)00581‑X 11738689
     [Google Scholar]
  148. SkovbjergS. RoosK. HolmS.E. Grahn HåkanssonE. NowrouzianF. IvarssonM. AdlerberthI. WoldA.E. Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media.Arch. Dis. Child.2008942929810.1136/adc.2008.137414 18713796
     [Google Scholar]
  149. MarchisioP. SantagatiM. ScillatoM. BaggiE. FattizzoM. RosazzaC. StefaniS. EspositoS. PrincipiN. Streptococcus salivarius 24SMB administered by nasal spray for the prevention of acute otitis media in otitis-prone children.Eur. J. Clin. Microbiol. Infect. Dis.201534122377238310.1007/s10096‑015‑2491‑x 26385346
     [Google Scholar]
  150. MarchisioP. EspositoS. PrincipiN. The evidence for applying Streptococcus salivarius 24SMB by nasal spray for preventing recurrent acute otitis media.Eur. J. Clin. Microbiol. Infect. Dis.201635111889189010.1007/s10096‑016‑2729‑2 27461220
     [Google Scholar]
  151. BuddenK.F. GellatlyS.L. WoodD.L.A. CooperM.A. MorrisonM. HugenholtzP. HansbroP.M. Emerging pathogenic links between microbiota and the gut–lung axis.Nat. Rev. Microbiol.2017151556310.1038/nrmicro.2016.142 27694885
     [Google Scholar]
  152. BassisC.M. Erb-DownwardJ.R. DicksonR.P. FreemanC.M. SchmidtT.M. YoungV.B. BeckJ.M. CurtisJ.L. HuffnagleG.B. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals.MBio201562e00037e1510.1128/mBio.00037‑15 25736890
     [Google Scholar]
  153. ForsytheP. Probiotics and lung diseases.Chest2011139490190810.1378/chest.10‑1861 21467057
     [Google Scholar]
  154. GoldinB.R. GorbachS.L. Clinical indications for probiotics: An overview.Clin. Infect. Dis.200846S2S96S10010.1086/523333 18181732
     [Google Scholar]
  155. KechaouN. ChainF. GratadouxJ.J. BlugeonS. BerthoN. ChevalierC. Le GofficR. CourauS. MolimardP. ChatelJ.M. LangellaP. Bermúdez-HumaránL.G. Identification of one novel candidate probiotic Lactobacillus plantarum strain active against influenza virus infection in mice by a large-scale screening.Appl. Environ. Microbiol.20137951491149910.1128/AEM.03075‑12 23263960
     [Google Scholar]
  156. TakedaS. TakeshitaM. KikuchiY. DashnyamB. KawaharaS. YoshidaH. WatanabeW. MugurumaM. KurokawaM. Efficacy of oral administration of heat-killed probiotics from Mongolian dairy products against influenza infection in mice: Alleviation of influenza infection by its immunomodulatory activity through intestinal immunity.Int. Immunopharmacol.201111121976198310.1016/j.intimp.2011.08.007 21871585
     [Google Scholar]
  157. GuillemardE. TonduF. LacoinF. SchrezenmeirJ. Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial.Br. J. Nutr.20101031586810.1017/S0007114509991395 19747410
     [Google Scholar]
  158. GuillemardE. TanguyJ. FlavignyA.L. de la MotteS. SchrezenmeirJ. Effects of consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 on common respiratory and gastrointestinal infections in shift workers in a randomized controlled trial.J. Am. Coll. Nutr.201029545546810.1080/07315724.2010.10719882 21504972
     [Google Scholar]
  159. StrasserB. GeigerD. SchauerM. GostnerJ. GattererH. BurtscherM. FuchsD. Probiotic supplements beneficially affect tryptophan–kynurenine metabolism and reduce the incidence of upper respiratory tract infections in trained athletes: A randomized, double-blinded, placebo-controlled trial.Nutrients201681175210.3390/nu8110752 27886064
     [Google Scholar]
  160. VieiraA.T. RochaV.M. TavaresL. GarciaC.C. TeixeiraM.M. OliveiraS.C. CassaliG.D. GambaC. MartinsF.S. NicoliJ.R. Control of Klebsiella pneumoniae pulmonary infection and immunomodulation by oral treatment with the commensal probiotic Bifidobacterium longum 51A.Microbes Infect.201618318018910.1016/j.micinf.2015.10.008 26548605
     [Google Scholar]
  161. MaldonadoJ. CañabateF. SempereL. VelaF. SánchezA.R. NarbonaE. López-HuertasE. GeerlingsA. ValeroA.D. OlivaresM. Lara-VillosladaF. Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants.J. Pediatr. Gastroenterol. Nutr.2012541556110.1097/MPG.0b013e3182333f18 21873895
     [Google Scholar]
  162. KumpuM. KekkonenR.A. KautiainenH. JärvenpääS. KristoA. HuovinenP. PitkärantaA. KorpelaR. HatakkaK. Milk containing probiotic Lactobacillus rhamnosus GG and respiratory illness in children: a randomized, double-blind, placebo-controlled trial.Eur. J. Clin. Nutr.20126691020102310.1038/ejcn.2012.62 22692023
     [Google Scholar]
  163. PowerD.A. BurtonJ.P. ChilcottC.N. DawesP.J. TaggJ.R. Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12.Eur. J. Clin. Microbiol. Infect. Dis.200827121261126310.1007/s10096‑008‑0569‑4 18560907
     [Google Scholar]
  164. HoltzmanM.J. ByersD.E. BenoitL.A. BattaileJ.T. YouY. AgapovE. ParkC. GraysonM.H. KimE.Y. PatelA.C. Immune pathways for translating viral infection into chronic airway disease.Adv. Immunol.200910224527610.1016/S0065‑2776(09)01205‑X 19477323
     [Google Scholar]
  165. YooJ. TcheurekdjianH. LynchS.V. CabanaM. BousheyH.A. Microbial manipulation of immune function for asthma prevention: Inferences from clinical trials.Proc. Am. Thorac. Soc.20074327728210.1513/pats.200702‑033AW 17607013
     [Google Scholar]
  166. RubinB.K. DhandR. RuppelG.L. BransonR.D. HessD.R. Respiratory care year in review 2010: part 1. asthma, COPD, pulmonary function testing, ventilator-associated pneumonia.Respir. Care201156448850210.4187/respcare.01286 21496376
     [Google Scholar]
  167. MorrowL.E. KollefM.H. CasaleT.B. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial.Am. J. Respir. Crit. Care Med.201018281058106410.1164/rccm.200912‑1853OC 20522788
     [Google Scholar]
  168. JancinB. Probiotic Helped Prevent VAP, C. difficile Disease.Chest Physician2009
     [Google Scholar]
  169. KlarinB. MolinG. JeppssonB. LarssonA. Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study.Crit. Care2008126R13610.1186/cc7109 18990201
     [Google Scholar]
  170. HarataG. HeF. HirutaN. KawaseM. KubotaA. HiramatsuM. YausiH. Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses.Lett. Appl. Microbiol.201050659760210.1111/j.1472‑765X.2010.02844.x 20438620
     [Google Scholar]
  171. HoriT. KiyoshimaJ. ShidaK. YasuiH. Effect of intranasal administration of Lactobacillus casei Shirota on influenza virus infection of upper respiratory tract in mice.Clin. Diagn. Lab. Immunol.20018359359710.1128/CDLI.8.3.593‑597.2001 11329464
     [Google Scholar]
  172. IzumoT. MaekawaT. IdaM. NoguchiA. KitagawaY. ShibataH. YasuiH. KisoY. Effect of intranasal administration of Lactobacillus pentosus S-PT84 on influenza virus infection in mice.Int. Immunopharmacol.20101091101110610.1016/j.intimp.2010.06.012 20601181
     [Google Scholar]
  173. ParkM.K. NgoVu. KwonY.M. LeeY.T. YooS. ChoY.H. HongS.M. HwangH.S. KoE.J. JungY.J. MoonD.W. JeongE.J. KimM.C. LeeY.N. JangJ.H. OhJ.S. KimC.H. KangS.M. Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity.PLoS One2013810e7536810.1371/journal.pone.0075368 24124485
     [Google Scholar]
  174. SandesaS. AlvimaL. SilvaaB. AcurciobL. SantosC. Selection of new lactic acid bacteria strains bearing probiotic features from mucosal microbiota of healthy calves: Looking for immunobiotics through in vitro and in vivo approaches for immunoprophylaxis applications.Microbiol. Res.201720011310.1016/j.micres.2017.03.008 28527759
     [Google Scholar]
  175. YounH.N. LeeD.H. LeeY.N. ParkJ.K. YukS.S. YangS.Y. LeeH.J. WooS.H. KimH.M. LeeJ.B. ParkS.Y. ChoiI.S. SongC.S. Intranasal administration of live Lactobacillus species facilitates protection against influenza virus infection in mice.Antiviral Res.201293113814310.1016/j.antiviral.2011.11.004 22120759
     [Google Scholar]
  176. YounH.N. LeeY.N. LeeD.H. ParkJ.K. YukS.S. LeeH.J. YeoJ.M. YangS.Y. LeeJ.B. ParkS.Y. ChoiI.S. SongC.S. Effect of intranasal administration of Lactobacillus fermentum CJL-112 on horizontal transmission of influenza virus in chickens.Poult. Sci.201291102517252210.3382/ps.2012‑02334 22991537
     [Google Scholar]
  177. BlaineyP.C. MillaC.E. CornfieldD.N. QuakeS.R. Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis.Sci. Transl. Med.20124153153ra13010.1126/scitranslmed.3004458 23019655
     [Google Scholar]
  178. FodorA.A. KlemE.R. GilpinD.F. ElbornJ.S. BoucherR.C. TunneyM.M. WolfgangM.C. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.PLoS One201279e4500110.1371/journal.pone.0045001 23049765
     [Google Scholar]
  179. GussA.M. RoeselersG. NewtonI.L.G. YoungC.R. Klepac-CerajV. LoryS. CavanaughC.M. Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis.ISME J.201151202910.1038/ismej.2010.88 20631810
     [Google Scholar]
  180. SegalL.N. RomW.N. WeidenM.D. Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs.Ann. Am. Thorac. Soc.201411110811610.1513/AnnalsATS.201310‑339FR 24460444
     [Google Scholar]
  181. ZhaoJ. SchlossP.D. KalikinL.M. CarmodyL.A. FosterB.K. PetrosinoJ.F. CavalcoliJ.D. VanDevanterD.R. MurrayS. LiJ.Z. YoungV.B. LiPuma, J.J. Decade-long bacterial community dynamics in cystic fibrosis airways.Proc. Natl. Acad. Sci. USA2012109155809581410.1073/pnas.1120577109 22451929
     [Google Scholar]
  182. BruzzeseE. RaiaV. GaudielloG. PolitoG. BuccigrossiV. FormicolaV. GuarinoA. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration.Aliment. Pharmacol. Ther.200420781381910.1111/j.1365‑2036.2004.02174.x 15379842
     [Google Scholar]
  183. FallahiG. MotamedF. YousefiA. ShafieyounA. NajafiM. KhodadadA. FarhmandF. AhmadvandA. RezaeiN. The effect of probiotics on fecal calprotectin in patients with cystic fibrosis.Turk. J. Pediatr.2013555475478 24382526
     [Google Scholar]
  184. del CampoR. GarrigaM. Pérez-AragónA. GuallarteP. LamasA. MáizL. BayónC. RoyG. CantónR. ZamoraJ. BaqueroF. SuárezL. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: A double blind prospective study.J. Cyst. Fibros.201413671672210.1016/j.jcf.2014.02.007 24636808
     [Google Scholar]
  185. BruzzeseE. RaiaV. SpagnuoloM.I. VolpicelliM. De MarcoG. MaiuriL. GuarinoA. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: A pilot study.Clin. Nutr.200726332232810.1016/j.clnu.2007.01.004 17360077
     [Google Scholar]
  186. Di NardoG. OlivaS. MenichellaA. PistelliR. BiaseR.V.D. PatriarchiF. CucchiaraS. StronatiL. Lactobacillus reuteri ATCC55730 in cystic fibrosis.J. Pediatr. Gastroenterol. Nutr.2014581818610.1097/MPG.0000000000000187 24121143
     [Google Scholar]
  187. JafariS-A. Mehdizadeh-HakkakA. KianifarH-R. HebraniP. AhanchianH. AbbasnejadE. Effects of probiotics on quality of life in children with cystic fibrosis; a randomized controlled trial.Iran. J. Pediatr.2013236669674 24910746
     [Google Scholar]
  188. WeissB. BujanoverY. YahavY. VilozniD. FiremanE. EfratiO. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: A pilot study.Pediatr. Pulmonol.201045653654010.1002/ppul.21138 20503277
     [Google Scholar]
  189. EgeM.J. MayerM. NormandA.C. GenuneitJ. CooksonW.O.C.M. Braun-FahrländerC. HeederikD. PiarrouxR. von MutiusE. Exposure to environmental microorganisms and childhood asthma.N. Engl. J. Med.2011364870170910.1056/NEJMoa1007302 21345099
     [Google Scholar]
  190. HiltyM. BurkeC. PedroH. CardenasP. BushA. BossleyC. DaviesJ. ErvineA. PoulterL. PachterL. MoffattM.F. CooksonW.O.C. Disordered microbial communities in asthmatic airways.PLoS One201051e857810.1371/journal.pone.0008578 20052417
     [Google Scholar]
  191. MarriP.R. SternD.A. WrightA.L. BillheimerD. MartinezF.D. Asthma-associated differences in microbial composition of induced sputum.J Allergy Clin Immunol.20131312346-52.e1-310.1016/j.jaci.2012.11.01323265859
     [Google Scholar]
  192. RoseM.A. SchubertR. SchulzeJ. ZielenS. Follow-up of probiotic Lactobacillus GG effects on allergic sensitization and asthma in infants at risk.Clin. Exp. Allergy201141121819182110.1111/j.1365‑2222.2011.03876.x 22107145
     [Google Scholar]
  193. Miraglia Del GiudiceM. IndolfiC. CapassoM. MaielloN. DecimoF. CiprandiG. Bifidobacterium mixture (B. longum BB536, B infantis M-63, B breve M-16V) treatment in children with seasonal allergic rhinitis and intermittent asthma.Ital. J. Pediatr.20174312510.1186/s13052‑017‑0340‑5 28270216
     [Google Scholar]
  194. SusantiN. BarliantoW. KalimH. KusumaH.C.S. Asthma clinical improvement and reduction in the number of CD4+CD25+foxp3+Treg and CD4+IL-10+ cells after administration of immunotherapy house dust mite and adjuvant probiotics and/or Nigella sativa powder in mild asthmatic children.IOSR J. Dent. Med. Sci.2013735059
     [Google Scholar]
  195. GutkowskiP. Madaliński, K.; Syczewska, M.; Grek, M.; Dmeńska, H.; Michałkiewicz, J. Effect of orally administered probiotic strains Lactobacillus and Bifidobacterium in children with atopic asthma.Cent. Eur. J. Immunol.2010354233238
     [Google Scholar]
  196. ElazabN. MendyA. GasanaJ. VieiraE.R. QuizonA. FornoE. Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials.Pediatrics20131323e666e67610.1542/peds.2013‑0246 23958764
     [Google Scholar]
  197. LarsenJ.M. MusavianH.S. ButtT.M. IngvorsenC. ThysenA.H. BrixS. Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology.Immunology2015144233334210.1111/imm.12376 25179236
     [Google Scholar]
  198. FeleszkoW. RossiG.A. KrenkeR. CanonicaG.W. Van GervenL. KalyuzhinO. Immunoactive preparations and regulatory responses in the respiratory tract: Potential for clinical application in chronic inflammatory airway diseases.Expert Rev. Respir. Med.202014660361910.1080/17476348.2020.1744436 32250709
     [Google Scholar]
  199. MorrisA. BeckJ.M. SchlossP.D. CampbellT.B. CrothersK. CurtisJ.L. FloresS.C. FontenotA.P. GhedinE. HuangL. JablonskiK. KleerupE. LynchS.V. SodergrenE. TwiggH. YoungV.B. BassisC.M. VenkataramanA. SchmidtT.M. WeinstockG.M. Comparison of the respiratory microbiome in healthy nonsmokers and smokers.Am. J. Respir. Crit. Care Med.2013187101067107510.1164/rccm.201210‑1913OC 23491408
     [Google Scholar]
  200. SzeM.A. DimitriuP.A. HayashiS. ElliottW.M. McDonoughJ.E. GosselinkJ.V. CooperJ. SinD.D. MohnW.W. HoggJ.C. The lung tissue microbiome in chronic obstructive pulmonary disease.Am. J. Respir. Crit. Care Med.2012185101073108010.1164/rccm.201111‑2075OC 22427533
     [Google Scholar]
  201. CarvalhoJ.L. MirandaM. FialhoA.K. Castro-Faria-NetoH. AnatrielloE. KellerA.C. AimbireF. Oral feeding with probiotic Lactobacillus rhamnosus attenuates cigarette smoke-induced COPD in C57Bl/6 mice: Relevance to inflammatory markers in human bronchial epithelial cells.PLoS One2020154e022556010.1371/journal.pone.0225560 32330145
     [Google Scholar]
  202. MortazE. van BergenhenegouwenJ. GeorgiouN. GarssenJ. KraneveldA. FolkertsG. Lactobacillus rhamnosus and Bifidobacterium breve suppress cigarette smoke induced CXCL-8 release by human macrophages.Eur. J. Pharmacol.2011668e11e1210.1016/j.ejphar.2011.09.219
     [Google Scholar]
  203. ChengM. QianL. ShenG. BianG. XuT. XuW. ShenG. HuS. Microbiota modulate tumoral immune surveillance in lung through a γδT17 immune cell-dependent mechanism.Cancer Res.201474154030404110.1158/0008‑5472.CAN‑13‑2462 24947042
     [Google Scholar]
  204. HosgoodH.D.III SapkotaA.R. RothmanN. RohanT. HuW. XuJ. VermeulenR. HeX. WhiteJ.R. WuG. WeiF. MongodinE.F. LanQ. The potential role of lung microbiota in lung cancer attributed to household coal burning exposures.Environ. Mol. Mutagen.201455864365110.1002/em.21878 24895247
     [Google Scholar]
  205. MorimotoK. TakeshitaT. NannoM. TokudomeS. NakayamaK. Modulation of natural killer cell activity by supplementation of fermented milk containing Lactobacillus casei in habitual smokers.Prev. Med.200540558959410.1016/j.ypmed.2004.07.019 15749143
     [Google Scholar]
  206. MortazE. AdcockI.M. RicciardoloF.L.M. VarahramM. JamaatiH. VelayatiA.A. FolkertsG. GarssenJ. Anti-Inflammatory Effects of Lactobacillus rahmnosus and Bifidobacterium breve on cigarette smoke activated human macrophages.PLoS One2015108e013645510.1371/journal.pone.0136455 26317628
     [Google Scholar]
  207. HanK.J. LeeN.K. ParkH. PaikH.D. Anticancer and Anti-Inflammatory Activity of Probiotic Lactococcus lactis NK34.J. Microbiol. Biotechnol.201525101697170110.4014/jmb.1503.03033 26165315
     [Google Scholar]
  208. LeeN.K. HanK.J. SonS.H. EomS.J. LeeS.K. PaikH.D. Multifunctional effect of probiotic Lactococcus lactis KC24 isolated from kimchi.Lebensm. Wiss. Technol.20156421036104110.1016/j.lwt.2015.07.019
     [Google Scholar]
  209. SivanA. CorralesL. HubertN. WilliamsJ.B. Aquino-MichaelsK. EarleyZ.M. BenyaminF.W. Man LeiY. JabriB. AlegreM.L. ChangE.B. GajewskiT.F. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy.Science201535062641084108910.1126/science.aac4255 26541606
     [Google Scholar]
  210. ZhouJ. KulasingheA. BogsethA. O’ByrneK. PunyadeeraC. PapautskyI. Isolation of circulating tumor cells in non-small-cell-lung-cancer patients using a multi-flow microfluidic channel.Microsyst. Nanoeng.201951810.1038/s41378‑019‑0045‑6 31057935
     [Google Scholar]
  211. DavisS.S. IllumL. The targeting of drugs using polymeric microspheres.Br. Polym. J.198315416016410.1002/pi.4980150404
     [Google Scholar]
  212. MatsuzakiT. YokokuraT. AzumaI. Anti-tumour activity of Lactobacillus casei on lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs.Cancer Immunol. Immunother.1985201182210.1007/BF00199768 3933816
     [Google Scholar]
  213. MatsuzakiT. YokokuraT. AzumaI. Antimetastatic effect of Lactobacillus casei YIT9018 (LC 9018) on a highly metastatic variant of B16 melanoma in C57BL/6J mice.Cancer Immunol. Immunother.19872429910510.1007/BF00205585 3103914
     [Google Scholar]
  214. Le NociV. GuglielmettiS. ArioliS. CamisaschiC. BianchiF. SommarivaM. StortiC. TriulziT. CastelliC. BalsariA. TagliabueE. SfondriniL. Modulation of pulmonary microbiota by antibiotic or probiotic aerosol therapy: a strategy to promote immunosurveillance against lung metastases.Cell Rep.201824133528353810.1016/j.celrep.2018.08.090 30257213
     [Google Scholar]
  215. MarslandB.J. TrompetteA. GollwitzerE.S. The gut–lung axis in respiratory disease.Ann. Am. Thorac. Soc.201512Suppl. 2S150S15610.1513/AnnalsATS.201503‑133AW 26595731
     [Google Scholar]
  216. TraversiL. Perez-MirandaJ. PolverinoE. Inhaled treatments and the future of respiratory diseases: Holding our breath.Respiration201997649850010.1159/000496357 31104061
     [Google Scholar]
  217. RaoS.S.C. RehmanA. YuS. de AndinoN.M. Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis.Clin. Transl. Gastroenterol.201896e16210.1038/s41424‑018‑0030‑7 29915215
     [Google Scholar]
  218. CaillardR. LapointeN. In vitro gastric survival of commercially available probiotic strains and oral dosage forms.Int. J. Pharm.20175191-212512710.1016/j.ijpharm.2017.01.019 28093323
     [Google Scholar]
  219. DodooC.C. WangJ. BasitA.W. StapletonP. GaisfordS. Targeted delivery of probiotics to enhance gastrointestinal stability and intestinal colonisation.Int. J. Pharm.20175301-222422910.1016/j.ijpharm.2017.07.068 28764983
     [Google Scholar]
  220. RodríguezG. RuizB. FaleirosS. VistosoA. MarróM.L. SánchezJ. UrzúaI. CabelloR. Probiotic compared with standard milk for high-caries children.J. Dent. Res.201695440240710.1177/0022034515623935 26747421
     [Google Scholar]
  221. ChavarriM. MaranonI. CarmenM. Encapsulation technology to protect probiotic bacteria.Probiotics; InTech201210.5772/50046
     [Google Scholar]
  222. GurramS. JhaD.K. ShahD.S. KshirsagarM.M. AminP.D. Insights on the critical parameters affecting the probiotic viability during stabilization process and formulation development.AAPS PharmSciTech202122515610.1208/s12249‑021‑02024‑8 34008083
     [Google Scholar]
  223. GbassiG.K. VandammeT. Probiotic encapsulation technology: from microencapsulation to release into the gut.Pharmaceutics20124114916310.3390/pharmaceutics4010149 24300185
     [Google Scholar]
  224. KitamuraY. ItohH. EchizenH. SatakeT. Experimental vacuum spray drying of probiotic foods included with lactic acid bacteria.J. Food Process. Preserv.200933671472610.1111/j.1745‑4549.2008.00299.x
     [Google Scholar]
  225. RiverosB. FerrerJ. BórquezR. Spray drying of a vaginal probiotic strain of Lactobacillus acidophilus.Dry. Technol.200927112313210.1080/07373930802566002
     [Google Scholar]
  226. ChávezB.E. LedeboerA.M. Drying of probiotics: Optimization of formulation and process to enhance storage survival.Dry. Technol.2007257-81193120110.1080/07373930701438576
     [Google Scholar]
  227. PerdanaJ. BereschenkoL. FoxM.B. KuperusJ.H. KleerebezemM. BoomR.M. SchutyserM.A.I. Dehydration and thermal inactivation of Lactobacillus plantarum WCFS1: Comparing single droplet drying to spray and freeze drying.Food Res. Int.20135421351135910.1016/j.foodres.2013.09.043
     [Google Scholar]
  228. TeixeiraP. CastroH. Mohácsi-FarkasC. KirbyR. Identification of sites of injury in Lactobacillus bulgaricus during heat stress.J. Appl. Microbiol.199783221922610.1046/j.1365‑2672.1997.00221.x 9281825
     [Google Scholar]
  229. ArepallyD. ReddyR.S. GoswamiT.K. RETRACTED: Studies on survivability, storage stability of encapsulated spray dried probiotic powder.Curr. Res. Food Sci.2020323524210.1016/j.crfs.2020.09.001 33103122
     [Google Scholar]
  230. ArepallyD. GoswamiT.K. Effect of inlet air temperature and gum Arabic concentration on encapsulation of probiotics by spray drying.Lebensm. Wiss. Technol.20199958359310.1016/j.lwt.2018.10.022
     [Google Scholar]
  231. BroeckxG. VandenheuvelD. ClaesI.J.J. LebeerS. KiekensF. Drying techniques of probiotic bacteria as an important step towards the development of novel pharmabiotics.Int. J. Pharm.20165051-230331810.1016/j.ijpharm.2016.04.002 27050865
     [Google Scholar]
  232. BroeckxG. VandenheuvelD. HenkensT. KiekensS. van den BroekM.F.L. LebeerS. KiekensF. Enhancing the viability of Lactobacillus rhamnosus GG after spray drying and during storage.Int. J. Pharm.20175341-2354110.1016/j.ijpharm.2017.09.075 28986319
     [Google Scholar]
  233. RutherfordW.M. AllenJ.E. SchlameusH.W. MangoldD.J. HarloweW.W. LebedaJ.R. Process for preparing rotary disc fatty acid microspheres of microorganisms.US005292657A
  234. WuW.-H. RoeW.S. GiminoV.G. SeriburiV. MartinD.E. KnappS.E. Low melt encapsulation with high laurate canola oil.USOO6153236A
  235. PopO.L. BrandauT. SchwinnJ. VodnarD.C. SocaciuC. The influence of different polymers on viability of Bifidobacterium lactis 300b during encapsulation, freeze-drying and storage.J. Food Sci. Technol.20155274146415510.1007/s13197‑014‑1441‑4 26139879
     [Google Scholar]
  236. CarvalhoA.S. SilvaJ. HoP. TeixeiraP. MalcataF.X. GibbsP. Survival of freeze-dried Lactobacillus plantarum and Lactobacillus rhamnosus during storage in the presence of protectants.Biotechnol. Lett.200224191587159110.1023/A:1020301614728
     [Google Scholar]
  237. JalaliM. AbediD. VarshosazJ. NajjarzadehM. MirlohiM. TavakoliN. Stability evaluation of freeze-dried Lactobacillus paracasei subsp. tolerance and Lactobacillus delbrueckii subsp. bulgaricus in oral capsules.Res. Pharm. Sci.2012713136 23181077
     [Google Scholar]
  238. ShimaM. MoritaY. YamashitaM. AdachiS. Protection of Lactobacillus acidophilus from the low pH of a model gastric juice by incorporation in a W/O/W emulsion.Food Hydrocoll.20062081164116910.1016/j.foodhyd.2006.01.001
     [Google Scholar]
  239. SultanaK. GodwardG. ReynoldsN. ArumugaswamyR. PeirisP. KailasapathyK. Encapsulation of probiotic bacteria with alginate–starch and evaluation of survival in simulated gastrointestinal conditions and in yoghurt.Int. J. Food Microbiol.2000621-2475510.1016/S0168‑1605(00)00380‑9 11139021
     [Google Scholar]
  240. Pimentel-GonzálezD.J. Campos-MontielR.G. Lobato-CallerosC. Pedroza-IslasR. Vernon-CarterE.J. Encapsulation of Lactobacillus rhamnosus in double emulsions formulated with sweet whey as emulsifier and survival in simulated gastrointestinal conditions.Food Res. Int.200942229229710.1016/j.foodres.2008.12.002
     [Google Scholar]
  241. KamalianN. MirhosseiniH. MustafaS. ManapM.Y.A. Effect of alginate and chitosan on viability and release behavior of Bifidobacterium pseudocatenulatum G4 in simulated gastrointestinal fluid.Carbohydr. Polym.201411170070610.1016/j.carbpol.2014.05.014 25037405
     [Google Scholar]
  242. SinghP. MedronhoB. AlvesL. da SilvaG.J. MiguelM.G. LindmanB. Development of carboxymethyl cellulose-chitosan hybrid micro- and macroparticles for encapsulation of probiotic bacteria.Carbohydr. Polym.2017175879510.1016/j.carbpol.2017.06.119 28917929
     [Google Scholar]
  243. OliveiraA.C. MorettiT.S. BoschiniC. BalieroJ.C.C. FreitasO. Favaro-TrindadeC.S. Stability of microencapsulated B. lactis (BI 01) and L. acidophilus (LAC 4) by complex coacervation followed by spray drying.J. Microencapsul.200724768569310.1080/02652040701532908 17763061
     [Google Scholar]
  244. Xavier dos SantosD. CasazzaA.A. AliakbarianB. BedaniR. SaadS.M.I. PeregoP. Improved probiotic survival to in vitro gastrointestinal stress in a mouse containing Lactobacillus acidophilus La-5 microencapsulated with inulin by spray drying.Lebensm. Wiss. Technol.20199940441010.1016/j.lwt.2018.10.010
     [Google Scholar]
  245. AnalA.K. SinghH. Recent advances in microencapsulation of probiotics for industrial applications and targeted delivery.Trends Food Sci. Technol.200718524025110.1016/j.tifs.2007.01.004
     [Google Scholar]
/content/journals/cnt/10.2174/2665978604666221122112434
Loading
Probiotic Formulation Development and Local Application with Focus on Local Buccal, Nasal and Pulmonary Application
Current Nutraceuticals 3, e221122211111 (2022); https://doi.org/10.2174/2665978604666221122112434
/content/journals/cnt/10.2174/2665978604666221122112434
/content/journals/cnt/10.2174/2665978604666221122112434
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): buccal application; encapsulation methods; formulation development; nasal application; Probiotics; pulmonary application

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test